Taro Pharmaceutical Industries Shares Near 52-Week Low - Market Mover
The shares closed 0.7% above its 52-week low of $52.61, with trading volume higher than its 30 day average
Nov 25, 2021 by Kwhen Finance Editors
Taro Pharmaceutical Industries (TARO) shares closed today at 0.7% above its 52 week low of $52.61, giving the company a market cap of $2B. The stock is currently down 25.7% year-to-date, down 18.4% over the past 12 months, and down 39.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.2%.
Trading Activity
- Trading volume this week was 18.5% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Taro Pharmaceutical Industries | -2.8 | -25.7 | -18.4 | -32.4 | 2.7 |
| Dow Jones Industrial Average | 0.0 | 18.8 | 23.1 | -2.4 | 22.9 |
| S&P 500 Index | 0.3 | 26.4 | 32.8 | -1.3 | 31.9 |
| Health Care | -0.2 | 16.6 | 22.8 | -3.8 | 23.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -385.9%
- The company's stock price performance over the past 12 months lags the peer average by -245.7%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Taro Pharmaceutical Industries | TARO | 0 | -25.7 | -18.4 | -32.4 | 2.7 |
| Peer Avg | N/A | 22.0 | 9.0 | 12.6 | -12.3 | 93.0 |
| Johnson & Johnson | JNJ | 23.7 | 4.7 | 14.5 | -9.9 | 14.9 |
| Pfizer Inc. | PFE | 14.9 | 44.2 | 45.3 | -3.0 | 58.0 |
| Merck & Co Inc | MRK | 29.1 | 3.9 | 6.7 | -9.6 | 448.8 |
| Novartis AG - ADR | NVS | 34.9 | -8.9 | -1.5 | -14.0 | 1.0 |
| Glaxosmithkline plc - ADR | GSK | 16.1 | 19.6 | 19.8 | -3.2 | 29.3 |
| Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | 13.3 | -9.4 | -9.1 | -34.3 | 6.1 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: